載入...
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors
BACKGROUND: The liver is the predominant site of metastases among patients with advanced neuroendocrine tumors (NETs). Prior retrospective studies have reported high response rates in patients treated with transarterial embolization (TAE). NETs are highly vascular and are known to express vascular e...
Na minha lista:
| 發表在: | Ann Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559904/ https://ncbi.nlm.nih.gov/pubmed/22317769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr614 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|